Application of Agatroban in Extracorporeal Membrane Oxygenation
In the process of extracorporeal membrane oxygenation(ECMO)support,in order to effectively prevent co-agulation complications,it is particularly important to select appropriate anticoagulant drugs.Agatroban,as a direct thrombin inhibitor(DTI),may be superior to unfractionated heparin(UFH)because of its controllable anticoagulant monitoring,excellent anticoagulant effect and good safety.This article reviewed the application of agatroban in ECMO,which provided a more individualized choice for anticoagulant therapy and further enriched the anticoagulant strategy of ECMO.
NETL
NSTL
万方数据
维普
